Internet Support Group for Parents of a Child With Neurofibromatosis Type 1
NCT ID: NCT02153931
Last Updated: 2019-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
33 participants
OBSERVATIONAL
2014-05-31
2019-01-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
\- Studies show that Internet Support Groups (ISGs) can help parents of children with chronic conditions. Researchers want to find out if ISGs can help parents of a child with the genetic disorder Neurofibromatosis Type 1 (NF1).
Objective:
\- To see if an ISG for parents with a child with NF1 can give the parents more social support and less anxiety.
Eligibility:
\- Adults age 18 and older with a child (age 0 25 years) with NF1.
Design:
* Participants will register for the study on a website hosted by the Children s Tumor Foundation.
* Participants will complete 5 questionnaires. These will be about their emotional well-being, their child s health status, and their contact information.
* The ISG will include a Discussion Forum that participants can enter 24 hours a day, 7 days a week. A professional moderator will post questions and discussion topics. The moderator can also respond to questions. They will be a psychologist, a psychology associate, or a nurse-practitioner. Each one will be highly experienced at working with young people with NF1 and their families.
* The ISG also will contain a chat room. Here participants can chat with other users in real time. The chat room will be open for one 90-minute session per week.
* The ISG will remain open for 8 weeks. Then participants will retake 4 of the questionnaires from the beginning of the study. They will also complete 1 other questionnaire about their experiences with the ISG. Information from any messages participants post on the ISG website will be collected.
* Three months after the ISG closes, participants will complete the questionnaires one final time.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-center Project: Spinal Abnormalities in Neurofibromatosis Type1 (NF1) Patients
NCT00667836
Resiliency Training in Adolescents With NF1 and NF2
NCT03873610
How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem
NCT01626846
Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.
NCT02078401
Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas
NCT00716469
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* The complex symptom profile in NF1 puts children and adolescents with this condition at risk for a variety of physical, cognitive, and social-emotional difficulties. Thus, caring for a child with a chronic medical condition such as NF1 can be challenging.
* Over the last two decades, researchers have been examining the use of internet support groups (ISGs) as a means of connecting individuals with similar conditions, diagnoses, or challenges to provide emotional and informational support.
* While the benefits of ISGs have been well documented in many studies of medical patients, very few have examined the use of ISGs in parents of children with chronic medical conditions. Further, no studies have been conducted on an ISG in parents of a child with NF1.
OBJECTIVES:
* The primary objective of this pilot study is to assess the effectiveness of an ISG designed for parents of children with NF1 on a measure of perceived social support.
* Secondary objectives are to assess effects of the ISG on self-efficacy, depression, and anxiety, and to explore themes and topics discussed in the ISG.
ELIGIBILITY:
Eligible participants must self-report:
* Being greater than or equal to 18 years of age
* Having a child with a diagnosis of NF1 between 0 and 25 years of age
* Living in the same home as the child with NF1
* Having regular access to a computer with internet capability
DESIGN:
* Parents of children with NF1 will be recruited through Dr. Widemann s NF1 patient database and through the Children s Tumor Foundation s (CTF) NF registry.
* Eligible participants will be emailed a link to access the study website through the CTF website. Due to the nature of the study, consent will be obtained online.
* After consenting, participants will be administered (electronically) baseline measures of perceived social support, self-efficacy, depression, and anxiety. After 8 weeks, participants will complete the measures again via the same website, as well as a post-study questionnaire assessing their experiences with participation. Measures will be repeated at 3-months post-intervention.
* Content analyses will be performed to identify themes and needs of the participants
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Volunteers
Parents of children with NF1
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Participants must report being at least 18 years of age.
Participants must report living in the same home as the child(ren) with NF1 a majority of the time.
Participants must report having regular access to a computer and internet connection.
Participants will indicate they do not have any plans to start any other internet support group for parents of children with NF during the study time period.
Participants must have the ability to read and communicate in the English language.
Participants must have the ability to understand and the willingness to provide an online informed consent document.
Exclusion Criteria
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Staci M Peron, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute (NCI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-C-0113
Identifier Type: -
Identifier Source: secondary_id
140113
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.